Pluri (PLUR) Gains from Investment Securities (2025)
Pluri (PLUR) posted quarterly Gains from Investment Securities of -$539000.0 for Q2 2025, down 3070.59% quarter-over-quarter from -$17000.0 in Q1 2025.
Pluri (PLUR) Gains from Investment Securities (2025) Analysis & Trends
Pluri (PLUR) has reported Gains from Investment Securities for 1 consecutive years, with -$539000.0 the latest figure, recorded in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -539,000.00 |
| Jun 30, 2025 | -539,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Mar 31, 2025 | -17,000.00 |